TargED is extremely pleased and proud to have raised €39 million in a Series A investment round! Together with an international investor syndicate we’ll pursue our common goal: to bring Microlyse into clinical development! Read press release
New Nordic fund focused on high-impact medical innovation Nine investments made over the first 16 months in early and late-stage healthcare companies. Two portfolio companies IPO’ed on NASDAQ New York December 9, 2021, Stockholm & Copenhagen: Eir Ventures Partners AB (“Eir Ventures” or “the Fund”), a Nordic Life Science Venture Capital manager, today announced the […]
European investors continue actively investing in healthcare. The survey held in May 2020 includes responses from 24 of the most influential European VCs, investing approximately EUR 15.5 billion in aggregate in the Healthcare sector.